These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10584566)

  • 1. [Treatment of testicular and second cancer].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2021-8. PubMed ID: 10584566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term side effects of chemotherapy for testicular cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
    BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
    Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J
    Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
    Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
    Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
    Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
    Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
    Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of testicular cancer and the development of secondary malignancies.
    Bokemeyer C; Schmoll HJ
    J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of good risk germ-cell tumours.
    Troost MM; Sternberg CN; de Wit R
    BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
    Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of testicular cancer.
    Huddart RA; Birtle AJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):123-38. PubMed ID: 15757445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.